Alignment Healthcare's revenue has scaled past $1.4 billion per quarter in 2026Q3, but top-line growth has decelerated from roughly 51% in 2024Q4 to about 37%, and the loss ratio of 86% to 90% keeps the combined ratio hovering near 100%, suggesting volume expansion has not yet translated into durable underwriting…
Price trend, volume and key moving averages
Trailing total returns as of 11/8/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC).
Check whether operating performance supports the current valuation.
Recent results and news deserve attention only when they alter the forward view.
| Quarter | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|
Q4 2026Latest Oct 29, 2026 | -$0.04-9.7% vs -$0.04 | $1.4B+3.5% vs $1.3B |
Q3 2026 Jul 30, 2026 | $0.17+31.8% vs $0.13 | $1.3B+2.0% vs $1.3B |
Q2 2026 Apr 30, 2026 | $0.05+400.0% vs $0.01 | $1.2B+1.4% vs $1.2B |
Q1 2026 Feb 26, 2026 | -$0.05+66.7% vs -$0.15 | $1.0B+0.9% vs $1.0B |
When a $12,000 hospital bill lands in a senior's lap, the instinct is to pay it off fast or put it on a credit card. That instinct can cost the family a coverage pathway most people never knew existed.
Alignment Healthcare (ALHC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Expansion into Bexar and Comal counties gives more than 392,000 Medicare beneficiaries access to Alignment's coordinated care model and personalized Medicare Advantage coverage. Expansion into Bexar and Comal counties gives more than 392,000 Medicare beneficiaries access to Alignment's coordinated care model and personalized Medicare Advantage coverage.
Growth into Kern, Kings and Tulare counties and an expanded provider network give California Medicare beneficiaries more local care options Growth into Kern, Kings and Tulare counties and an expanded provider network give California Medicare beneficiaries more local care options
Benchmark ALHC against direct peers instead of judging its metrics in isolation.
Key metrics vs top competitors for Alignment Healthcare, Inc. (ALHC)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $7.34 | $1.52B | 52.92 | 46.06% | 0.59% | 12.46% | — | |
| $69.74 | $34.45B | 23.59 | 19.44% | 0.75% | 6.76% | — | |
| $208.99 | $10.91B | -224.24 | 11.75% | -0.11% | -1.17% | — | |
| $83.85 | $106.99B | 9.79 | 7.85% | 2.63% | 14.1% | 3.19% | |
| $433.74 | $52.08B | 42.44 | 10.06% | 0.81% | 6.68% | 0.82% | |
| $425.62 | $92.3B | 18.02 | 12.62% | 2.55% | 11.56% | 1.62% |
Alignment Healthcare, Inc. (ALHC) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Verify the primary filings, follow material updates, and answer the remaining questions.
Alignment Healthcare, Inc. (ALHC) SEC filings — annual & quarterly reports (10-K, 10-Q)
Oct 29, 2026·SEC
Oct 8, 2026·SEC
Jul 30, 2026·SEC
Get notified when ALHC posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
Alignment Healthcare, Inc. (ALHC) stock FAQ — growth, dividends, profitability & financials explained
Alignment Healthcare, Inc. (ALHC) grew revenue by 35.9% over the trailing twelve months, compared with the twelve months before.
Yes. Alignment Healthcare, Inc. (ALHC) earned $28.9M in net income over the trailing twelve months (a 0.6% net margin).
Alignment Healthcare, Inc. (ALHC) had a return on equity (ROE) of 12.5% over the trailing twelve months. That is in line with the market's typical 10-15%.
Alignment Healthcare, Inc. (ALHC) has a combined ratio of 99.6%. A ratio below 100% indicates underwriting profitability.
